RetroSense Therapeutics launches clinical trials on 1st human patients

Ann Arbor-based RetroSense Therapeutics has begun patient trials on its gene therapy technology (it helps restore vision), Which is the first big step toward commercialization.
News from Concentrate

Be Sociable, Share!

Comments are closed.